Llwytho...
Prasugrel in critically ill patients
While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Thromb Haemost |
|---|---|
| Prif Awduron: | , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Schattauer GmbH
2017
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/ https://ncbi.nlm.nih.gov/pubmed/28692105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|